Pharmaceutical formulation
US5705482A · kind A · utility
34Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1995 |
| Grant date | Jan 6, 1998 |
| Priority date | — |
| Expiry date | Jan 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation comprising a growth hormone and Leu-His-Leu as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.